Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty

Peter A. Lee, Karen Klein, Nelly Mauras, Kirk E. Neely, Clifford A. Bloch, Lois Larsen, Cynthia Mattia-Goldberg, Kristof Chwalisz

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences